Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Neuronetics ( (STIM) ) has issued an update.
Neuronetics, Inc. and Greenbrook TMS Inc. have announced an interim order for their proposed all-stock transaction arrangement, which, pending satisfaction of conditions, will see Neuronetics acquire all issued and outstanding Greenbrook shares. The arrangement will result in Neuronetics and Greenbrook shareholders owning approximately 57% and 43% of the combined company, respectively. Both companies’ boards have unanimously approved the deal, which is subject to shareholder votes at upcoming special meetings. This move is anticipated to create a leading entity in the Transcranial Magnetic Stimulation market, offering non-invasive treatments for mental health disorders.
See more data about STIM stock on TipRanks’ Stock Analysis page.